Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences (“Kuros” or “the Company”), a leader in next generation bone graft technologies, today announced it wi…
Kuros Biosciences (“Kuros” or “the Company”), a leader in next generation bone graft technologies, today announced it wi…
. New level 1 data from the MAXA Clinical Trial comparing standalone MagnetOs to the gold standard autograft in the ch…
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in th…
First investigational trial of drug-biologic bone graft for spinal fusion 50 patients have been enrolled in the Phase 2…
Soft tissue sarcomas are a rare group of malignant tumors arising from connective tissue cells, of which more than 70 di…
Large quantities of the protein IGF2BP2 not only make bowel cancer grow faster, but they also make it resistant to commo…
Wie lassen sich Kamerabilder bei einer minimalinvasiven Operation nutzen, um zu beurteilen, ob das operierte Organ ausre…
Radioactivity can save lives. When neither chemotherapy or surgery nor radiation from the outside help against a tumor,…
. First investigational trial of drug-biologic bone graft for spinal fusion No drug-related Serious Adverse Events (SA…
ASC Oncology proudly announces new partnership with Tamer Group Across borders, cancer is one of those diseases that is…